The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible

Abstract

This prospective clinical trial revealed that routine determination of the fetal D status from maternal plasma is feasible. Noninvasive fetal RHD genotyping can be considered as sensitive as the traditional postnatal serologic assay.